Anaplastic large cell lymphoma risk factors: Difference between revisions
Jump to navigation
Jump to search
Kamal Akbar (talk | contribs) No edit summary |
No edit summary |
||
| (4 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Anaplastic large cell lymphoma}} | {{Anaplastic large cell lymphoma}} | ||
{{CMG}}; {{AE}} {{AS}} | {{CMG}}; {{AE}} {{AS}}, {{kakbar}} | ||
==Overview== | ==Overview== | ||
There are no established risk factors for anaplastic large cell lymphoma. | There are no established risk factors for anaplastic large cell lymphoma. | ||
==Risk Factors== | ==Risk Factors== | ||
There are no real established risk factors for anaplastic large cell lymphoma, but the following are some known predisposing factors: | *There are no real established risk factors for anaplastic large cell lymphoma, but the following are some known predisposing factors:<ref name="pmid28061468">{{cite journal| author=Mereu E, Pellegrino E, Scarfò I, Inghirami G, Piva R| title=The heterogeneous landscape of ALK negative ALCL. | journal=Oncotarget | year= 2017 | volume= 8 | issue= 11 | pages= 18525-18536 | pmid=28061468 | doi=10.18632/oncotarget.14503 | pmc=5392347 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28061468 }} </ref><ref name="pmid28895885">{{cite journal| author=Cao S, Nambudiri VE| title=Anaplastic Lymphoma Kinase in Cutaneous Malignancies. | journal=Cancers (Basel) | year= 2017 | volume= 9 | issue= 9 | pages= | pmid=28895885 | doi=10.3390/cancers9090123 | pmc=5615338 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28895885 }} </ref> | ||
*Male predominance | **Male predominance | ||
*2;5 translocation in the | **2;5 translocation in the sub-types of Anaplastic large cell lymphoma | ||
**Textured breast implants (also know as breast implant associated anaplastic large cell lymphoma)<ref name="pmid28497021">{{cite journal| author=Clemens MW, Nava MB, Rocco N, Miranda RN| title=Understanding rare adverse sequelae of breast implants: anaplastic large-cell lymphoma, late seromas, and double capsules. | journal=Gland Surg | year= 2017 | volume= 6 | issue= 2 | pages= 169-184 | pmid=28497021 | doi=10.21037/gs.2016.11.03 | pmc=5409903 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28497021 }} </ref><ref name="pmid26628470">{{cite journal| author=Clemens MW, Medeiros LJ, Butler CE, Hunt KK, Fanale MA, Horwitz S et al.| title=Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant-Associated Anaplastic Large-Cell Lymphoma. | journal=J Clin Oncol | year= 2016 | volume= 34 | issue= 2 | pages= 160-8 | pmid=26628470 | doi=10.1200/JCO.2015.63.3412 | pmc=4872006 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26628470 }} </ref><ref name="pmid30373708">{{cite journal| author=Kricheldorff J, Fallenberg EM, Solbach C, Gerber-Schäfer C, Rancsó C, Fritschen UV| title=Breast Implant-Associated Lymphoma. | journal=Dtsch Arztebl Int | year= 2018 | volume= 115 | issue= 38 | pages= 628-635 | pmid=30373708 | doi=10.3238/arztebl.2018.0628 | pmc=6218708 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30373708 }} </ref><ref name="pmid28715445">{{cite journal| author=Di Napoli A, Pepe G, Giarnieri E, Cippitelli C, Bonifacino A, Mattei M et al.| title=Cytological diagnostic features of late breast implant seromas: From reactive to anaplastic large cell lymphoma. | journal=PLoS One | year= 2017 | volume= 12 | issue= 7 | pages= e0181097 | pmid=28715445 | doi=10.1371/journal.pone.0181097 | pmc=5513491 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28715445 }} </ref> | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Latest revision as of 15:50, 7 March 2019
|
Anaplastic large cell lymphoma Microchapters |
|
Differentiating Anaplastic large cell lymphoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Anaplastic large cell lymphoma risk factors On the Web |
|
American Roentgen Ray Society Images of Anaplastic large cell lymphoma risk factors |
|
Directions to Hospitals Treating Anaplastic large cell lymphoma |
|
Risk calculators and risk factors for Anaplastic large cell lymphoma risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2], Kamal Akbar, M.D.[3]
Overview
There are no established risk factors for anaplastic large cell lymphoma.
Risk Factors
- There are no real established risk factors for anaplastic large cell lymphoma, but the following are some known predisposing factors:[1][2]
References
- ↑ Mereu E, Pellegrino E, Scarfò I, Inghirami G, Piva R (2017). "The heterogeneous landscape of ALK negative ALCL". Oncotarget. 8 (11): 18525–18536. doi:10.18632/oncotarget.14503. PMC 5392347. PMID 28061468.
- ↑ Cao S, Nambudiri VE (2017). "Anaplastic Lymphoma Kinase in Cutaneous Malignancies". Cancers (Basel). 9 (9). doi:10.3390/cancers9090123. PMC 5615338. PMID 28895885.
- ↑ Clemens MW, Nava MB, Rocco N, Miranda RN (2017). "Understanding rare adverse sequelae of breast implants: anaplastic large-cell lymphoma, late seromas, and double capsules". Gland Surg. 6 (2): 169–184. doi:10.21037/gs.2016.11.03. PMC 5409903. PMID 28497021.
- ↑ Clemens MW, Medeiros LJ, Butler CE, Hunt KK, Fanale MA, Horwitz S; et al. (2016). "Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant-Associated Anaplastic Large-Cell Lymphoma". J Clin Oncol. 34 (2): 160–8. doi:10.1200/JCO.2015.63.3412. PMC 4872006. PMID 26628470.
- ↑ Kricheldorff J, Fallenberg EM, Solbach C, Gerber-Schäfer C, Rancsó C, Fritschen UV (2018). "Breast Implant-Associated Lymphoma". Dtsch Arztebl Int. 115 (38): 628–635. doi:10.3238/arztebl.2018.0628. PMC 6218708. PMID 30373708.
- ↑ Di Napoli A, Pepe G, Giarnieri E, Cippitelli C, Bonifacino A, Mattei M; et al. (2017). "Cytological diagnostic features of late breast implant seromas: From reactive to anaplastic large cell lymphoma". PLoS One. 12 (7): e0181097. doi:10.1371/journal.pone.0181097. PMC 5513491. PMID 28715445.